Breast MRI Case Review
Technical Issues and Complex Cases ARCHIVE
Format: Archived Webinar
MD Credit: 1.0 AMA PRA Category 1
RT Credit: 1.0 ARRT Category A (accepted by ARMRIT)
Fee for Credit Certificate: $0
Course Overview
In the United States, breast cancer is the most common non-skin cancer and the second leading cause of cancer-related death in women.[1] Early detection and treatment can often mean the difference between life and death.
Based on recent evidence on the efficacy of breast magnetic resonance imaging (MRI) screening in high-risk patients, the American Cancer Society (ACS) has issued guidelines for the early detection of breast cancer that include MRI.[2] Additionally, MRI is emerging as an important tool in the treatment of breast cancer patients to evaluate the extent of disease, assess tumor response to neoadjuvant chemotherapy, and for preoperative planning.
This activity brings to learners the opportunity to view a variety of breast MRI cases as expert faculty share their experience and approach to breast MRI in their practice.
[1] Source for incidence and mortality data: Surveillance, Epidemiology, and End Results (SEER) Program and the National Center for Health Statistics. Available at http://seer.cancer.gov
[]2] Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.
Educational Objectives
At the conclusion of this activity, participants should be better able to:
Accreditation and Credit
ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Physicians
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.
The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. For more information go to http://www.uems.eu/uems-activities/accreditation/eaccme.
Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.
How to Participate
There are no fees or prerequisite for this program.
How to Receive Credit
Catherine M. Appleton, MD
Assistant Professor, Radiology
Division of Diagnostic Radiology
Chief, Breast Imaging Section
Washington University School of Medicine
St. Louis, MO
Dr. Appleton received her medical degree from University of Florida College of Medicine, Gainesville. She completed her residency and fellowship in diagnostic radiology at Washington University St. Louis, Mallinckrodt Institute of Radiology, and became board certified in 2005.
Dr. Appleton has co-authored several peer-review articles and was listed in Best Doctors in America 2011-2012. Her areas of clinical interest are magnetic resonance imaging of the breast, sonography, mammography, and breast ultrasound.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Catherine M. Appleton, MD has received royalties from Oxford University Press and received fees from Hologic, Inc. for consulting, as well as for non-CME/CE services.
The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Sharon Cancino
Laura Excell, ND, NP, MS, MA, LPC, NCC
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD
Linda McLean, MS
Victoria Phoenix, BS
Patricia Staples, MSN, NP-C, CCRN
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10
Jointly Provided by
This activity is supported by an independent educational grant from Hologic
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.